Worked with C-suite and an accounting firm to conduct an economic analysis, structure, and implement intercompany payments and agreements in preparation for an IPO of an innovative biotech incubator. The analysis included valuation of a unique biotech development and production facility, R&D, engineering and management services.
ITR World Tax Guide 2025: Rebel Curd and David Kemp recognized
Congratulations to Rebel Curd and David Kemp for their recent recognition as “highly regarded” leaders in International Tax Review’s (ITR) 2025 World Tax...